TramerMR, CarrollD, CampbellFA, ReynoldsDJ, MooreRA, McQuayHJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: Quantitative systematic review. BMJ, 2001; 323:16–21.
4.
BealJE, OlsonR, LaubensteinL, MoralesJO, BellmanP, YangcoB, LefkowitzL, PlasseTF, ShepardKV. Dronabinol as a treatment for anorexia with weight loss in patients with AIDS. J Pain Symptom Manage, 1995; 10:89–97.
5.
JatoiA, WindschitlHE, LoprinziCL, SloanJA, DakhilSR, MailliardJA, PundaleekaS, KardinalCG, FitchTR, KrookJE, NovotnyPJ, ChristensenB. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: A North Central Cancer Treatment Group Study. J Clin Oncol, 2002; 20:567–573.
6.
SlatkinNE. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: Beyond prevention of acute emesis. J Support Oncol, 2007; 5,Suppl 3:1–9.
7.
DavisM, MaidaV, DaeninckP, PergolizziJ. The emerging role of cannabinoid neuromodulators in symptom management. Support Care Cancer, 2007; 15:63–71.
8.
Ben AmarM. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol, 2006; 105:1–25.
9.
Nabilone (Cesamet) for chemotherapy-induced nausea and vomiting. Med Lett Drugs Ther, 2006; 48:103–104.
10.
NemechekPM, PolskyB, GottliebMS. Treatment Guidelines for HIV-associated wasting. Mayo Clinic Proc, 2000; 75:386–394.
